Abstract
Excess hair growth (hypertrichosis) may occur spontaneously or due to various triggers. The estimation of how much hair is too much hair is a matter of individual perception. In many cases undesired hair growth has a strong impact on a subject’s quality of life due to esthetic disturbance. In rare cases hypertrichosis is innate. Numerous triggers may result in excess hair growth: induced by drugs, paraneoplastic, or androgenetic. The most common cause of undesired hair growth in females is hirsutism, in more than 90% of cases due to hyperandrogenism and polycystic ovary syndrome. Various treatment options will be discussed in this chapter. Most effective reduction of hair growth have been reported after combination of topical, systemic, light assisted treatment options and lifestyle modification. In any case, treatment of excess hair growth represents a challenge for dermatologists and endocrinologists.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- ACTH:
-
Adrenocorticotropic hormone
- AGA:
-
Androgenetic alopecia
- AGS:
-
Adrenogenital syndrome
- AN:
-
Acanthosis nigricans
- CMA:
-
Chlormadidoneacetate
- CPA:
-
Cyproteronacetate
- DHT:
-
Dihydrotestosterone
- FSH:
-
Follicle-stimulating hormone
- GnRH:
-
Gonadotropin-releasing hormone
- HAIR-AN:
-
Hyperandrogenism insulin resistancy and AN
- IGF:
-
Insulin-like growth factor
- IPL:
-
Intensive pulsed light
- LH:
-
Luteinizing hormone
- PCOS:
-
Polycystic ovary syndrome
- SAHA:
-
Seborrhea acne, hirsutism, alopecia
- SHBG:
-
Sex hormone binding globuline
References
Asunción M, Calvo, R.M., San Millán, J.L., Sancho, J., Avila, S. and Escobar-Morreale, H.F. 2000. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. Journal of Clinical Endocrinology and Metabolism 85, 2434–2438.
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H.F., Futterweit, W., Janssen, O.E., Legro, R.S., Norman, R.J., Taylor, A.E. and Witchel, S.F., 2008. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertility and Sterility 91, 456–488.
Dawber, R.P. and Rundegren, J., 2003. Hypertrichosis in females applying minoxidil topical solution and in normal controls. Journal of the European Academy of Dermatology and Venereology 17, 271–275.
De Vries, T.W., De Langen-Wouterse, J.J., De Jong-Van den Berg, L.T. and Duiverman, E.J., 2007. Hypertrichosis as a side effect of inhaled steroids in children. Pediatric Pulmonology 42, 370–373.
Diamanti-Kandarakis, E. and Dunaif, A., 1996. New perspectives in polycystic ovary syndrome. Trends in Endocrinology and Metabolism 7, 267–271.
Dunaif, A. 1997. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrinologic Review 18, 774–800.
Ehrmann, D.A., 2005. Polycystic ovary syndrome. New England Journal of Medicine 352, 1223–1236.
El-Husseini, A., El-Basuony, F., Mahmoud, I., Sheashaa, H., Sabry, A., Hassan, R., Taha, N., Hassan, N., Sayed-Ahmad, N. and Sobh, M., 2005. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience. Nephrology, Dialysis and Transplant 20, 2433–2438.
Farquhar, C., Lee, O., Toomath, R. and Jepson, R., 2003. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database Systemical Reveview CD000194.
Ferriman, D. and Gallwey, J.D. 1961. Clinical assessment of body hair growth in women. Journal of Clinical Endocrinolology and Metabolism 21, 1440–1447.
Giovannini, S. 1985. Ueber die durch die elektrolytische Epilation hervorgerufenen histologischen Veranderungen. Archives of Dermatology and Syphilology 32, 3–64.
Grossman, M.C., Dierickx, C., Farinelli, W., Flotte, T. and Anderson, R.R., 1996. Damage to hair follicles by normal-mode ruby laser pulses. Journal of the American Academy of Dermatology 35, 889–894.
Hahn, S., Janssen, O.E., Tan, S., Pleger, K., Mann, K., Schedlowski, M., Kimmig, R., Benson, S., Balamitsa, E. and Elsenbruch, S., 2005. Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. European Journal of Endocrinology. 153, 853–860.
Hassan, A. and Gordon, C.M. 2007. Polycystic ovary syndrome update in adolescence. Current Opinion in Pediatrics 19, 389–397.
Hatch, R., Rosenfield, R.L., Kim, M.H. and Tredway, D., 1981. Hirsutism: implications, etiology, and management. American Journal of Obstetrics and Gynecology 140, 815–830.
Heutling, D., Schulz, H., Randeva, H., Dodt, C. and Lehnert, H., 2007. Das polyzystische Ovarsyndrom: Prototyp eines kardiometabolischen Syndroms. Der Internist 48, 144–153.
Kim, Y.J., Han, J.H., Kang, H.Y., Lee, E.S. and Kim, Y.C., 2008. Androgen receptor overexpression in Becker nevus: histopathologic and immunohistochemical analysis. Journal of Cutaneous Pathology 35, 1121–1126.
Kopera, D. 2003. Hair reduction: 48 months of experience with 800nm diode laser. Cosmetic Laser Therapy 5, 146–149.
Lumachi, F. and Basso, S.M. 2010. Medical treatment of hirsutism in women. Curriculum of Medicine and Chemistry 17, 2530–2538.
Mendiratta, V., Harjai, B. and Gupta, T., 2008. Hypertrichosis lanuginosa congenita. Pediatric Dermatology 25, 483–484.
Pasquali, R. and Gambineri, A. 2006. Insulin-sensitizing agents in polycystic ovary syndrome. European Journal of Endocrinology 154, 763–775.
Radmanesh, M., 2008. Paradoxical hypertrichosis, leukotrichia and folliculitis are four major complications of intense pulsed light hair removal therapy. Journal of Dermatological Treatment 19, 360–363
Randall, V.A. 2000. Androgens: the main regulator of human hair growth. In: Camacho, F.M., Randall, V.A. and Price, V.H. (eds.) Hair and its disorders: biology, pathology and management; Martin Dunitz Ltd., London, UK, pp. 69–82.
Rashid, R.M. and White, L.E. 2007. A hairy development in hypertrichosis: a brief review of Ambras syndrome. Dermatolgical Online J 13, 8.
Rigopoulos, D. and Georgala, S. 2000. Pathogenesis of hirsutism. In: Camacho, F.M., Randall, V.A. and Price, V.H. (eds.) Hair and its disorders: biology, pathology and management. Martin Dunitz Ltd., London, UK, pp. 33–35.
Rosenfield, R.L. 2005. Hirsutism. New England Journal of Medicine 353, 2578–2588.
Sadick, N.S. 2005. Combination radiofrequency and light energies: electro-optical synergy technology in esthetic medicine. Dermatologic Surgery 31, 1211–1217.
Schmidt, J.B., Huber, J. and Spona, J., 1985. Medroxyprogesterone acetate therapy in hirsutism. British Journal of Dermatology 113, 161–165.
Schroeter, C.A., Sharma, S., Mbonu, N.C., Reineke, T. and Neumann, H.A., 2006. Blond hair removal using ELOS systems. Journal of Cosmetic Laser Therapy 8: 82–86.
Sinclair, R. 2000. Observations on the clinical features of hirsutism. In: Camacho, F.M., Randall, V.A. and Price, V.H. (eds.) Hair and its disorders: biology, pathology and management. Martin Dunitz Ltd., London, UK, pp. 339–346.
Smith, S.R., Piacquadio, D.J., Beger, B. and Littler, C., 2006. Eflornithine cream combined with laser therapy in the management of unwanted facial hair growth in women: a randomized trial. Dermatologic Surgery 32, 1237–1243.
Swiglo, B.A., Cosma, M., Flynn, D.N., Kurtz, D.M., Labella, M.L., Mullan, R.J., Erwin, P.J. and Montori, V.M., 2008. Clinical review: antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials. Journal of Clinical Endocrinology and Metabolism 93, 1153–1560.
Tannir, D. and Leshin, B. 2001. Sugaring: an ancient method of hair removal. Dermatologic Surgery 27, 309–311.
The Rotterdam ESHRE/ASRM-Sponsored consensus workshop group, 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 19, 41–47.
Tosti, A., Misciali, C., Piraccini, B.M., Peluso, A.M. and Bardazzi, F., 1994. Drug-induced hair loss and hair growth. Incidence, management and avoidance. Drug Safety 10, 310–317.
Unluhizarci, K., Sahin, Y. and Kelestimur, F., 2005. The evaluation and treatment of hirsute women. Womens Health 1, 429–435.
Vulink, A.J., and Ten Bokkel Huinink, D., 2007. Acquired hypertrichosislanuginosa: a rare cutaneous paraneoplastic syndrome. Journal of Clinical Oncology 25, 1625–1626.
Yildiz, B.O., Yarali, H., Oguz, H. and Bayraktar, M., 2003. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. Journal of Clinical Endocrinolology and Metabolism 88, 2031–2036.
Acknowledgements
Appreciation goes to our excellent clinical photographers, lead by Werner Stieber, who contributed with their artistic skills in the production of the figures shown in this chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Rights and permissions
Copyright information
© 2012 Wageningen Academic Publishers
About this chapter
Cite this chapter
Kopera, D. (2012). Excess hair growth. In: Preedy, V.R. (eds) Handbook of hair in health and disease. Human Health Handbooks no. 1, vol 1. Wageningen Academic Publishers. https://doi.org/10.3920/978-90-8686-728-8_6
Download citation
DOI: https://doi.org/10.3920/978-90-8686-728-8_6
Publisher Name: Wageningen Academic Publishers
Online ISBN: 978-90-8686-728-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)